Targeting cancer with precision: neoantigen vaccines show promise

In an elegant fusion of science and medicine, neoantigen cancer vaccines are emerging as a formidable strategy in the battle against cancer. These vaccines, a testament to the power of personalized medicine, target cancer’s unique protein signatures, rallying the immune system for a precise and potent attack.

Unlocking the almond genome: unraveling the secrets of heterozygosity

A pivotal study has unlocked the genetic complexities of almonds, highlighting a significant degree of heterozygosity and the influence of structural variants on gene expression. The research rigorously delineates allele-specific expression patterns, offering vital insights into the genetic traits that govern almond variability.

Clear Labs to Lead Session on Whole Genome Sequencing at AACC Annual Scientific Meeting in Chicago

Clear Labs harnesses the power of next-generation sequencing (NGS) to simplify complex workflows for clinical and applied markets. By creating a fully automated platform that brings together DNA sequencing, robotics and cloud-based analytics, Clear Labs liberates genomics to deliver increased clarity. Clear Labs’ turnkey platform accelerates outcomes and improves accuracy for detection and surveillance of infectious diseases. With a novel approach, Clear Labs is helping the world better understand, track and mitigate tomorrow’s novel pathogens.

Artificial Intelligence in Personalized Medicine, Genomic Sequencing Advances, Human Brain Organogenesis, Building Trust with Patients, Guiding Patient Decisions with Mass Spectrometry, and Much More to Be Explored at 2022 AACC

At the 2022 AACC Annual Scientific Meeting & Clinical Lab Expo, laboratory medicine experts will present the cutting-edge research and technology that is revolutionizing clinical testing and patient care.